- Foreword
- Abbreviations
- Contributors
- Chapter 1 The current classification of bipolar disorders
- Chapter 2 Should the bipolar disorders be modelled dimensionally or categorically?
- Chapter 3 The treatment of bipolar disorder in its early stages: current techniques, challenges, and future outlook
- Chapter 4 Evidence-based treatment of mania
- Chapter 5 The treatment of bipolar mixed states
- Chapter 6 The treatment of rapid cycling bipolar disorder
- Chapter 7 Evidence-based treatment of bipolar depression
- Chapter 8 Evidence-based maintenance treatment of bipolar disorder
- Chapter 9 The treatment of bipolar II disorder
- Chapter 10 The treatment of cyclothymia
- Chapter 11 Psychological interventions for early stage bipolar disorder
- Chapter 12 Psychotherapeutic interventions for bipolar disorder
- Chapter 13 The role of psychoeducation in the management of bipolar disorder
- Chapter 14 Functional remediation therapy for bipolar disorder
- Chapter 15 Predominant polarity, polarity index, and treatment selection in bipolar disorder
- Chapter 16 The assessment and management of suicide risk in bipolar disorder
- Chapter 17 Treatment implications for bipolar disorder co-occurring with anxiety syndromes and substance abuse
- Chapter 18 The impact of psychiatric co-morbidity in the treatment of bipolar disorder: focus on co-occurring attention deficit hyperactivity disorder and eating disorders
- Chapter 19 Bidirectional relationships between general medical conditions and bipolar disorder: treatment considerations
- Chapter 20 The treatment of bipolar disorder in women
- Chapter 21 The treatment of bipolar disorder in children and adolescents
- Chapter 22 The treatment of bipolar disorder in the elderly
- Chapter 23 The management of treatment-resistant bipolar disorder
- Chapter 24 Staging and neuroprogression in bipolar disorder: treatment implications
- Chapter 25 Pharmacotherapy of bipolar disorder: impact on neurocognition
- Chapter 26 Cognitive enhancement in bipolar disorder: current evidence and methodological considerations
- Chapter 27 The role of electroconvulsive therapy in the treatment of bipolar disorder
- Chapter 28 Neuromodulatory approaches for bipolar disorder: current evidences and future perspectives
- Chapter 29 The role of complementary and alternative therapies for the management of bipolar disorder
- Chapter 30 Novel therapeutic targets for bipolar disorder
- Chapter 31 The treatment of bipolar disorder in the era of personalized medicine: myth or promise?
- Index
(p. 369) Pharmacotherapy of bipolar disorder: impact on neurocognition
- Chapter:
- (p. 369) Pharmacotherapy of bipolar disorder: impact on neurocognition
- Author(s):
Vicent Balanzá-Martínez
, Sofia Brissos
, Maria Lacruz
, and Rafael Tabarés-Seisdedos
- DOI:
- 10.1093/med/9780198748625.003.0025
Neurocognitive dysfunction is a core feature of bipolar disorder (BD), which may be further compounded by several clinical factors, such as medications. There is growing interest on the potential impact of pharmacotherapy (lithium, anticonvulsants, antipsychotics, and other) on neurocognition. This chapter summarizes a critical, descriptive update of the literature, mostly focused on human data. Based on current studies, medication-associated neurocognitive side effects cannot be clearly distinguished from those intrinsic to BD. Moreover, available research is limited by several methodological flaws. We suggest some likely profitable directions to move the field forward, as well as several recommendations to manage cognitive deficits in clinical practice. The neurocognitive impact of medications used to treat BD clearly warrants further, higher-quality research.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Foreword
- Abbreviations
- Contributors
- Chapter 1 The current classification of bipolar disorders
- Chapter 2 Should the bipolar disorders be modelled dimensionally or categorically?
- Chapter 3 The treatment of bipolar disorder in its early stages: current techniques, challenges, and future outlook
- Chapter 4 Evidence-based treatment of mania
- Chapter 5 The treatment of bipolar mixed states
- Chapter 6 The treatment of rapid cycling bipolar disorder
- Chapter 7 Evidence-based treatment of bipolar depression
- Chapter 8 Evidence-based maintenance treatment of bipolar disorder
- Chapter 9 The treatment of bipolar II disorder
- Chapter 10 The treatment of cyclothymia
- Chapter 11 Psychological interventions for early stage bipolar disorder
- Chapter 12 Psychotherapeutic interventions for bipolar disorder
- Chapter 13 The role of psychoeducation in the management of bipolar disorder
- Chapter 14 Functional remediation therapy for bipolar disorder
- Chapter 15 Predominant polarity, polarity index, and treatment selection in bipolar disorder
- Chapter 16 The assessment and management of suicide risk in bipolar disorder
- Chapter 17 Treatment implications for bipolar disorder co-occurring with anxiety syndromes and substance abuse
- Chapter 18 The impact of psychiatric co-morbidity in the treatment of bipolar disorder: focus on co-occurring attention deficit hyperactivity disorder and eating disorders
- Chapter 19 Bidirectional relationships between general medical conditions and bipolar disorder: treatment considerations
- Chapter 20 The treatment of bipolar disorder in women
- Chapter 21 The treatment of bipolar disorder in children and adolescents
- Chapter 22 The treatment of bipolar disorder in the elderly
- Chapter 23 The management of treatment-resistant bipolar disorder
- Chapter 24 Staging and neuroprogression in bipolar disorder: treatment implications
- Chapter 25 Pharmacotherapy of bipolar disorder: impact on neurocognition
- Chapter 26 Cognitive enhancement in bipolar disorder: current evidence and methodological considerations
- Chapter 27 The role of electroconvulsive therapy in the treatment of bipolar disorder
- Chapter 28 Neuromodulatory approaches for bipolar disorder: current evidences and future perspectives
- Chapter 29 The role of complementary and alternative therapies for the management of bipolar disorder
- Chapter 30 Novel therapeutic targets for bipolar disorder
- Chapter 31 The treatment of bipolar disorder in the era of personalized medicine: myth or promise?
- Index